| Revenue | 294.98a | 371.92a |
| Cost of sales | -253.2a | -310.94a |
| Gross profit | 41.78a | 60.97a |
| Selling expenses | -14.05a | -16.05a |
| General and administrative expenses | -6.12a | -5.64a |
| Other income | 8.66a | 19a |
| Other expenses | -21.87a | -26.73a |
| (Impairment loss)/reversal of impairment loss on trade receivables (including interest on trade receivables) | -0.45a | -0.23a |
| Operating profit | 7.95a | 31.32a |
| Share of profit/(loss) of investees accounted for using the equity method | -0.14a | -1.62a |
| Finance income | 1.48a | 3.05a |
| Finance costs | -1.61a | -2.15a |
| Net finance income/(costs) | -0.13a | 0.9a |
| Impairment (loss)/reversal of impairment loss on other financial assets | -0.06a | -0.04a |
| Profit before tax | 7.62a | 30.56a |
| Income tax | -6.24a | -9.59a |
| Net profit | 1.38a | 20.97a |
| Net profit attributable to | 1.38a | 20.97a |
| Owners of the parent | 1.47a | 20.92a |
| Non-controlling interests | -0.09a | 0.05a |